NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
Post-LOEnorethindrone acetate and ethinyl estradiol and ferrous fumarate
ANDAORALTABLET
Approved
Sep 2017
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
3/8 — Basic
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (norethindrone acetate and ethinyl estradiol and ferrous fumarate) by Ichnos Glenmark Innovation is ovulation. Approved for pregnancy in women. First approved in 2017.
Drug data last refreshed Yesterday
Mechanism of Action
ovulation.
Indications (1)
Company
Worked on NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE at Ichnos Glenmark Innovation? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.